Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: FLEBAVEN
Active substances:
Estonian, English, Latin
ATC code: C05CA03
Dosage form: film-coated tablet
Strength: 500mg
Legal status for supply*: Not subject to medicinal prescription
Summary of product characteristics (SPC):  (last updated May 9, 2022)
Package information leaflet (PIL): EST  (last updated May 9, 2022)
Labelling:  (last updated November 29, 2021)
Indication: is indicated in adults for: - Treatment of signs and symptoms of chronic venous disease, such as pain, feeling of heaviness, leg tiredness, restless legs, night cramps, leg oedema and trophic changes. - Treatment of symptoms related to acute haemorrhoidal disease.
Safety features: No
Marketing authorization holder: KRKA, d.d., Novo mesto 
Marketing authorization number: 948417 
Marketing authorization issued on: September 12, 2017 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Decentralised 
Assessment report:  (last updated September 12, 2017) 
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1706565  FLEBAVEN  film-coated tablet  500mg 15TK  OTC           
1706576  FLEBAVEN  film-coated tablet  500mg 30TK  OTC           
1706587  FLEBAVEN  film-coated tablet  500mg 60TK  OTC           
1706598  FLEBAVEN  film-coated tablet  500mg 90TK  OTC           
1706600  FLEBAVEN  film-coated tablet  500mg 120TK  OTC           
1748864  FLEBAVEN  film-coated tablet  500mg 150TK  OTC           
1748875  FLEBAVEN  film-coated tablet  500mg 180TK  OTC           
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere